The Oncology / Hematology Channel

Treatment for CLL, Multiple Myeloma, and NHL

Betsy O’Donnell, MD, Dana-Farber Cancer Institute, Boston, MA, provides an overview of topics from Day 1 of the 2023 Best of Hematology Conference. Dr O’Donnell discusses the triplet regimen of acalabrutinib, venetoclax, and obinutuzumab in patients with high-risk CLL. Dr O’Donnell also discusses multiple myeloma and anti-BCMA CAR T-cell therapies.

More in Oncology / Hematology

► 53:59

The Cancer Detectives | Full Documentary | AMERICAN EXPERIENCE | PBS

Oncology

This video shares the journey of how the pap smear, a crucial test for cervical cancer, became a routine part of healthcare for women. It highlights the diverse group who...

► 04:09

Cancer-busting Vaccines are Coming: Here’s How They Work

Oncology

Most vaccines help the immune system learn to identify and fight off harmful viruses or bacteria before someone gets sick. But, scientists are also creating vaccines to treat cancer after...

► 1:12:21

Intercepting Ovarian Cancer

Ob/Gyn

Angela Belcher, PhD; Sangeeta Bhatia, MD, PhD; and Paula Hammond, PhD, from the Koch Institute at MIT, Cambridge, MA, present multi-dimensional approaches to early detection in ovarian cancer. They also...

► 03:25

Cervical Cancer Prevention and HPV | Duke Health

Ob/Gyn

Emma Rossi, MD, a gynecologic oncologist at Duke Health, discusses cervical cancer prevention and HPV. Dr Rossi explains that cervical cancer is the third most common gynecologic cancer in the...